Caixa Capital Risc et al. invest in Pevesa Biotech
Caixa Capital Risc has led a €1.6m funding round for Spanish biotech firm Pevesa Biotech.
Co-funding was provided by current Pevesa shareholders Suanfarma Biotech and Milar Ventures. Caixa invested through Caixa Innvierte Industria, an industrial technology fund containing €23m.
The fresh funding will enable the company to expand its production facilities and sales network.
Company
Founded in 1996 and based in Seville, Pevesa Biotech is a biotechnology firm that focuses on plant proteins, with applications in organic farming and food.
Pevesa has 17 members of staff and a €2.3m turnover, which it intends to triple in the next four years.
People
Carlos Trenchs is a director at Caixa.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








